Stefan J Friedrichsdorf1, Andrea Postier Nugent. 1. Department of Pain Medicine, Palliative Care and Integrative Medicine, Children's Hospitals and Clinics of Minnesota, Minnesota 55404, USA. stefan.friedrichsdorf@childrensMN.org
Abstract
PURPOSE OF REVIEW: Many children with cancer suffer from neuropathic pain. However, there are no published pediatric randomized controlled trials (RCTs), nor agreed upon pediatric treatment recommendations. Pediatric neuropathic pain in patients with malignancies is often underassessed and undertreated with ineffective therapies. RECENT FINDINGS: This article describes main themes in the literature and commonly used treatment strategies. SUMMARY: A combination of integrative, rehabilitative, and supportive therapies with pharmacotherapy, including first line medications such as NSAIDs, opioids, low-dose tricyclics, and gabapentinoids, appear to be successful treatment strategies. There is a dearth of evidence regarding the management of neuropathic pain in children with cancer; studies, especially RCTs, are desperately needed.
PURPOSE OF REVIEW: Many children with cancer suffer from neuropathic pain. However, there are no published pediatric randomized controlled trials (RCTs), nor agreed upon pediatric treatment recommendations. Pediatric neuropathic pain in patients with malignancies is often underassessed and undertreated with ineffective therapies. RECENT FINDINGS: This article describes main themes in the literature and commonly used treatment strategies. SUMMARY: A combination of integrative, rehabilitative, and supportive therapies with pharmacotherapy, including first line medications such as NSAIDs, opioids, low-dose tricyclics, and gabapentinoids, appear to be successful treatment strategies. There is a dearth of evidence regarding the management of neuropathic pain in children with cancer; studies, especially RCTs, are desperately needed.
Authors: Robert W Gereau; Kathleen A Sluka; William Maixner; Seddon R Savage; Theodore J Price; Beth B Murinson; Mark D Sullivan; Roger B Fillingim Journal: J Pain Date: 2014-10-29 Impact factor: 5.820
Authors: Doralina L Anghelescu; Brenda D Steen; Huiyun Wu; Jianrong Wu; Najat C Daw; Bhaskar N Rao; Michael D Neel; Fariba Navid Journal: Pediatr Blood Cancer Date: 2016-08-30 Impact factor: 3.167
Authors: Erik A H Loeffen; Leontien C M Kremer; Marianne D van de Wetering; Renée L Mulder; Anna Font-Gonzalez; Lee L Dupuis; Fiona Campbell; Wim J E Tissing Journal: Pediatr Blood Cancer Date: 2019-03-07 Impact factor: 3.838
Authors: Stefan J Friedrichsdorf; James Giordano; Kavita Desai Dakoji; Andrew Warmuth; Cyndee Daughtry; Craig A Schulz Journal: Children (Basel) Date: 2016-12-10
Authors: Stefan J Friedrichsdorf; Andrea C Postier; Gail S Andrews; Karen Es Hamre; Rose Steele; Harold Siden Journal: J Pain Res Date: 2017-07-31 Impact factor: 3.133